CD24 and breast carcinoma: Evidence from in vitro studies [34] demonstrated that the overexpression of CD24 was associated with the inhibition of stem-like properties in breast cancer cells, and another study [35] suggested that the lack of CD24 in breast cancer cells was associated with resistance against chemotherapeutics.